Moreover, a remarkable correlation was found between PD-L1 DNA in circulating EVs and tumour volumes of up to 60 cm3 in GBM patient samples, suggesting the use of EV PD-L1 DNA as a biomarker for GBM. The gene discussed is CD274; the disease is neoplasm.